Eton Pharmaceuticals Stock Market Value
| ETON Stock | USD 3.62 0.08 2.16% |
| Symbol | Eton |
Eton Pharmaceuticals Price To Book Ratio
Is Eton Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Eton Pharmaceuticals. If investors know Eton will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Eton Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.13) | Earnings Share 0.03 | Revenue Per Share 1.335 | Quarterly Revenue Growth 0.502 | Return On Assets 0.0124 |
The market value of Eton Pharmaceuticals is measured differently than its book value, which is the value of Eton that is recorded on the company's balance sheet. Investors also form their own opinion of Eton Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Eton Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Eton Pharmaceuticals' market value can be influenced by many factors that don't directly affect Eton Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Eton Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Eton Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Eton Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Eton Pharmaceuticals 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Eton Pharmaceuticals' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Eton Pharmaceuticals.
| 05/01/2024 |
| 05/31/2024 |
If you would invest 0.00 in Eton Pharmaceuticals on May 1, 2024 and sell it all today you would earn a total of 0.00 from holding Eton Pharmaceuticals or generate 0.0% return on investment in Eton Pharmaceuticals over 30 days. Eton Pharmaceuticals is related to or competes with China Pharma, Alimera Sciences, China SXT, Petros Pharmaceuticals, Cronos, OrganiGram Holdings, and Aurora Cannabis. Eton Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing and commercializing pharmaceutical... More
Eton Pharmaceuticals Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Eton Pharmaceuticals' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Eton Pharmaceuticals upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.08) | |||
| Maximum Drawdown | 18.1 | |||
| Value At Risk | (5.85) | |||
| Potential Upside | 4.25 |
Eton Pharmaceuticals Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Eton Pharmaceuticals' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Eton Pharmaceuticals' standard deviation. In reality, there are many statistical measures that can use Eton Pharmaceuticals historical prices to predict the future Eton Pharmaceuticals' volatility.| Risk Adjusted Performance | (0.04) | |||
| Jensen Alpha | (0.27) | |||
| Total Risk Alpha | (0.35) | |||
| Treynor Ratio | 0.7695 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Eton Pharmaceuticals' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Eton Pharmaceuticals Backtested Returns
Eton Pharmaceuticals secures Sharpe Ratio (or Efficiency) of -0.0754, which denotes the company had a -0.0754% return per unit of risk over the last 3 months. Eton Pharmaceuticals exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Eton Pharmaceuticals' Mean Deviation of 2.21, standard deviation of 3.49, and Variance of 12.17 to check the risk estimate we provide. The firm shows a Beta (market volatility) of -0.36, which means possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Eton Pharmaceuticals are expected to decrease at a much lower rate. During the bear market, Eton Pharmaceuticals is likely to outperform the market. Eton Pharmaceuticals has an expected return of -0.27%. Please make sure to confirm Eton Pharmaceuticals potential upside, as well as the relationship between the rate of daily change and relative strength index , to decide if Eton Pharmaceuticals performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.15 |
Insignificant predictability
Eton Pharmaceuticals has insignificant predictability. Overlapping area represents the amount of predictability between Eton Pharmaceuticals time series from 1st of May 2024 to 16th of May 2024 and 16th of May 2024 to 31st of May 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Eton Pharmaceuticals price movement. The serial correlation of 0.15 indicates that less than 15.0% of current Eton Pharmaceuticals price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.15 | |
| Spearman Rank Test | 0.18 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Eton Pharmaceuticals lagged returns against current returns
Autocorrelation, which is Eton Pharmaceuticals stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Eton Pharmaceuticals' stock expected returns. We can calculate the autocorrelation of Eton Pharmaceuticals returns to help us make a trade decision. For example, suppose you find that Eton Pharmaceuticals has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Eton Pharmaceuticals regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Eton Pharmaceuticals stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Eton Pharmaceuticals stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Eton Pharmaceuticals stock over time.
Current vs Lagged Prices |
| Timeline |
Eton Pharmaceuticals Lagged Returns
When evaluating Eton Pharmaceuticals' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Eton Pharmaceuticals stock have on its future price. Eton Pharmaceuticals autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Eton Pharmaceuticals autocorrelation shows the relationship between Eton Pharmaceuticals stock current value and its past values and can show if there is a momentum factor associated with investing in Eton Pharmaceuticals.
Regressed Prices |
| Timeline |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Eton Pharmaceuticals Correlation, Eton Pharmaceuticals Volatility and Eton Pharmaceuticals Alpha and Beta module to complement your research on Eton Pharmaceuticals. To learn how to invest in Eton Stock, please use our How to Invest in Eton Pharmaceuticals guide.You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.
Complementary Tools for Eton Stock analysis
When running Eton Pharmaceuticals' price analysis, check to measure Eton Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Eton Pharmaceuticals is operating at the current time. Most of Eton Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Eton Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Eton Pharmaceuticals' price. Additionally, you may evaluate how the addition of Eton Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios |
Eton Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.